IRONWOOD PHARMACEUTICALS INC Quarterly Depreciation in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Ironwood Pharmaceuticals Inc quarterly/annual Depreciation history and growth rate from Q1 2018 to Q1 2024.
  • Ironwood Pharmaceuticals Inc Depreciation for the quarter ending March 31, 2024 was $513K, a 79.4% increase year-over-year.
  • Ironwood Pharmaceuticals Inc annual Depreciation for 2023 was $1.58M, a 11.1% increase from 2022.
  • Ironwood Pharmaceuticals Inc annual Depreciation for 2022 was $1.42M, a 6.89% decline from 2021.
  • Ironwood Pharmaceuticals Inc annual Depreciation for 2021 was $1.52M, a 57.3% decline from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $513K +$227K +79.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $286K -$69K -19.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $355K -$55K -13.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $410K -$272K -39.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $682K -$6K -0.87% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $688K -$1.1M -61.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 $1.79M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.